MOUs in the Pharmaceuticals Industry
14 Contracts & Agreements
- Akorn (1 contract)
- Amneal Pharmaceuticals, Inc. (1)
- Canbiola, Inc. (1)
- CANNAPOWDER, INC. (1)
- Eloxx Pharmaceuticals, Inc. (1)
- Endo Pharmaceuticals Solutions Inc. (1)
- IMAGING3 INC (1)
- Jaguar Health, Inc. (1)
- Kaya Holdings, Inc. (2)
- MJ Holdings, Inc. (1)
- OncoMed Pharmaceuticals Inc (1)
- OSI PHARMACEUTICALS INC (1)
- TAURIGA SCIENCES, INC. (1)
- Binding Memorandum of Understanding, dated June 30, 2023, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc., Iliad Research and Trading, L.P., Uptown Capital, LLC and... (Jaguar Health, Inc., Filed With SEC on August 14, 2023)
- Memorandum of Understanding (IMAGING3 INC, Filed With SEC on March 28, 2022)
- Memorandum of Understanding between DuraMed, Sam, and ZetrOZ (Canbiola, Inc., Filed With SEC on January 30, 2019)
- Memorandum of Understanding by and between MJ Holdings, Inc. and Andy Zhang (MJ Holdings, Inc., Filed With SEC on November 15, 2018)
- Memorandum of Understanding dated October 8, 2018 between Canna Powder Ltd., a subsidiary of the Registrant, and UNV Medicine Ltd (CANNAPOWDER, INC., Filed With SEC on November 14, 2018)
- Memorandum of Understanding, dated December 16, 2017, by and among Amneal Pharmaceuticals LLC, Paul M. Bisaro, Impax Laboratories, Inc., Amneal Holdings, LLC and Atlas Holdings,... (Amneal Pharmaceuticals, Inc., Filed With SEC on April 13, 2018)
- Memorandum of Understanding, dated March 13, 2018, by and between Eloxx Pharmaceuticals, Inc. and Dr. Silvia Noiman (Eloxx Pharmaceuticals, Inc., Filed With SEC on March 16, 2018)
- MEMORANDUM OF UNDERSTANDING (OncoMed Pharmaceuticals Inc, Filed With SEC on May 11, 2012)
- Memorandum of Understanding (Kaya Holdings, Inc., Filed With SEC on October 27, 2011)
- Memorandum of Understanding Strategic Partnership Agreement (Kaya Holdings, Inc., Filed With SEC on October 27, 2011)
- MEMORANDUM OF UNDERSTANDING ("Agreement") (TAURIGA SCIENCES, INC., Filed With SEC on May 23, 2011)
- MEMORANDUM OF UNDERSTANDING (Endo Pharmaceuticals Solutions Inc., Filed With SEC on February 5, 2009)
- EXCLUSIVE MEMORANDUM OF UNDERSTANDING (Akorn, Filed With SEC on October 30, 2007)
- EX-10.55: LETTER OF UNDERSTANDING (OSI PHARMACEUTICALS INC, Filed With SEC on March 16, 2006)
